RSS   Newsletter   Contact   Advertise with us

Audentes Therapeutics to invest over $100 million in Sanford, North Carolina

Share on Twitter Share on LinkedIn
Christian Fernsby ▼ | February 20, 2020
Audentes Therapeutics, a genetic medicines company, will create 209 new jobs in Lee County, investing $109 million to locate a manufacturing facility in Sanford, North Carolina.
Sanford, North Carolina
Business in America   Sanford, North Carolina
An Astellas company, Audentes Therapeutics focuses on developing and commercializing innovative genetic medicines that can offer transformative benefits to patients.

Topics: Audentes Therapeutics North Carolina

Audentes will develop a 135,000 square foot, state of the art, large scale gene therapy manufacturing facility in Sanford.

The initial phase of the capital investment is planned to occur over approximately 18 months, with the plant expected to become operational in 2021.

The remaining investment will take place over two additional planned expansion phases.